Missed GME or NVDA? Donโt Miss the Next One.โ
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Onemednet Corp. (ONMD) Stock Forecast & Price Prediction United States | NASDAQ | Healthcare | Health Information Services
$0.41
-0.03 (-6.86%)10 Quality Stocks Worth Considering Now
Researching OneMedNet (ONMD) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on ONMD and similar high-potential opportunities.
ONMD has shown a year-to-date change of -69.9% and a 1-year change of -19.6%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for ONMD. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for ONMD.
Date | Firm | Analyst | Rating | Change | Price Target |
---|
The following stocks are similar to OneMedNet based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Onemednet Corp. has a market capitalization of $12.61M with a P/E ratio of 45.0x. The company generates $643,000 in trailing twelve-month revenue with a -43.7% profit margin.
Revenue growth is -92.4% quarter-over-quarter, while maintaining an operating margin of -10,253.8% and return on equity of +63.5%.
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Provides health information exchange and analytics solutions.
The company generates revenue by offering innovative platforms that facilitate secure medical data exchange and management for healthcare providers. These solutions enhance decision-making and operational efficiency, allowing clients like hospitals and clinics to improve patient outcomes while reducing costs.
Onemednet Corp. is positioned within the growing healthcare IT market, focusing on interoperability and accessibility of health data. Its services align with the ongoing digital transformation in healthcare, catering to the increasing demand for efficient and secure data practices.
Healthcare
Health Information Services
22
Mr. Aaron Green
United States
2019
HealthVerity has integrated OneMedNet's imaging data into its Marketplace, enhancing access to regulatory-grade imaging data for life sciences research across a large healthcare ecosystem.
The integration enhances data accessibility for life sciences, potentially driving innovation and research efficiency, which could positively impact stock prices and market positions of involved companies.
OneMedNet partners with Protege to provide real-time access to multimodal patient data, enhancing AI development in healthcare through improved dataset availability.
OneMedNet's partnership with Protege enhances access to valuable healthcare data, potentially accelerating AI advancements and improving market position, influencing investor sentiment and stock performance.
OneMedNet has partnered with Datavant to enhance access to tokenized health data for life sciences, utilizing OneMedNet's extensive patient and clinical study network.
OneMedNet's collaboration with Datavant enhances access to valuable health data, potentially boosting innovation in life sciences and attracting investment by improving research efficiency and outcomes.
OneMedNet Corporation appointed Dr. Kenneth Alleyne, an orthopedic surgeon, to its Board of Directors. He will chair the Audit Committee, contributing his expertise in healthcare and corporate governance.
Dr. Alleyne's appointment enhances OneMedNet's governance and expertise in healthcare, potentially boosting investor confidence and the company's strategic direction.
OneMedNet Corporation (Nasdaq: ONMD) regained compliance with Nasdaq Listing Rule 5550(b)(2) as its market value exceeded $35 million for 10 consecutive business days.
OneMedNet's compliance with Nasdaq listing rules enhances its market credibility, potentially attracting more investors and stabilizing its stock price, which is crucial for future growth.
OneMedNet Corporation (Nasdaq: ONMD) has regained compliance with Nasdaq Listing Rule 5550(a)(2) after its stock closed at $1.00 or higher for 10 consecutive days.
OneMedNet's compliance with Nasdaq's listing rule enhances its credibility and stability, potentially boosting investor confidence and reducing volatility in its stock price.
Analyst forecasts for Onemednet Corp. (ONMD) are not currently available. The stock is trading at $0.41.
Analyst ratings for ONMD are not currently available. The stock is currently trading at $0.41. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
Price predictions from Wall Street analysts for ONMD are not currently available. The stock is trading at $0.41.
The company generates revenue by offering innovative platforms that facilitate secure medical data exchange and management for healthcare providers. These solutions enhance decision-making and operational efficiency, allowing clients like hospitals and clinics to improve patient outcomes while reducing costs.
Price targets from Wall Street analysts for ONMD are not currently available. The stock is trading at $0.41.
Price targets from Wall Street analysts for ONMD are not currently available. The stock is trading at $0.41.
Analyst ratings for ONMD are not currently available. The stock is trading at $0.41.
Stock price projections, including those for Onemednet Corp., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.